Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia · Delayed Price · Currency is SAR 111.00
0.00 (0.00%)
Jul 2, 2026, 3:19 PM AST
Dallah Healthcare Company Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Dallah Healthcare Company stock has a consensus rating of "Hold" and an average price target of SAR 128.61. The average 1-year stock price forecast is 15.86% higher than the current stock price, while the lowest is SAR 92.00 (-17.12%) and the highest is SAR 160.00 (+44.14%).
Price Target: SAR 128.61 (+15.86%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Dallah Healthcare Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 2 | 3 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 5 | 4 | 3 | 2 | 2 | 3 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
4.53B
from 4.07B
Increased by 11.49%
Revenue Next Year
4.92B
from 4.53B
Increased by 8.58%
EPS This Year
5.04
from 5.32
Decreased by -5.24%
EPS Next Year
5.37
from 5.04
Increased by 6.43%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.7B | ||
| Avg | 4.5B | ||
| Low | 4.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.3% | ||
| Avg | 11.5% | ||
| Low | 8.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.93 | ||
| Avg | 5.04 | ||
| Low | 4.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.5% | ||
| Avg | -5.2% | ||
| Low | -20.5% |